
Alicia M. Douglas
Featured in:
cell.com
Articles
-
Aug 2, 2023 |
cell.com | Bryce Thomas |Michelle Monje |Nicholas A. Vitanza |Alicia M. Douglas
HighlightsThe lack of effective therapies for DMG stems from tumor location, complex molecular features, and immunosuppressive tumor immune microenvironment. CAR therapy can effectively elicit an immune response in immunologically cold diffuse midline glioma tumors. Locoregional infusions of CAR T cells minimize therapy related toxicities, promote proinflammatory immune engagement, and may reduce immunosuppressive responses.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →